John B Moriarty
CIK 1564621 · Chief Legal Officer · last filed 2026-02-27
John B Moriarty is a Chief Legal Officer who has filed 43 SEC Form 4 insider transactions across 5 companies since 2018. The most recent filing, for RNAM, was dated Feb 27, 2026. Across all open-market trades the lifetime net is −$252.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $922.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$922.3K
5
43
-$252.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Avidity Biosciences, Inc. (RNAM) Delisted | Chief Legal Officer | 0 | — | — | $0 | 1 | 2026-02-27 |
| RNA | Chief Legal Officer | 74,557 | $12.37 | $922.3K | -$252.8K | 5 | 2026-01-09 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | Chief Legal Officer | 0 | $58.70 | $0 | $0 | 2 | 2024-01-23 |
| OLMA | EVP, Ch. Legal Officer & Sec. | — | $9.87 | — | $0 | 3 | 2023-02-02 |
| PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | EVP, General Counsel | 0 | — | — | $0 | 7 | 2020-07-02 |
Recent Filings
43 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-27 | Avidity Biosciences, Inc. (RNAM) Delisted | Disp (D) | −92,054 | $0 | EDGAR |
| 2026-01-09 | RNA | Sell (S) | −2,374 | -$171.5K | EDGAR |
| 2025-12-19 | RNA | Mixed | +29,176 | -$1.93M | EDGAR |
| 2025-08-05 | RNA | Sell (S) | −2,245 | -$81.3K | EDGAR |
| 2025-01-08 | RNA | Grant (A) | +25,000 | $0 | EDGAR |
| 2024-08-05 | RNA | Grant (A) | +25,000 | $0 | EDGAR |
| 2024-01-23 | Mirati Therapeutics, Inc. (MRTX) Delisted | Disp (D) | −72,335 | $0 | EDGAR |
| 2023-08-10 | Mirati Therapeutics, Inc. (MRTX) Delisted | Grant (A) | +22,297 | $825.0K | EDGAR |
| 2023-02-02 | OLMA | Grant (A) | — | $0 | EDGAR |
| 2022-02-03 | OLMA | Grant (A) | — | $0 | EDGAR |